Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name file name title title grouped question UIN question first answered answering member label
tabling member	label

Search

420086

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much his Department spent on seasonal influenza vaccination public awareness campaigns in 2014-15; and how much it plans to spend on such campaigns in 2015-16.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	10938
answer	answer is ministerial correction date of answer 19/10/2015 answer text <p>Public Health England’s annual seasonal flu vaccination programme campaign to educate the population about the risks of catching flu, the benefits of having a flu vaccination and promoting uptake of the flu vaccination, cost £1.6 million in 2014-15.</p><br /><p>For 2015-16, a joint campaign between Public Health England and NHS England launched on 15 October. This is part of a wider piece of activity to raise awareness of winter services, including flu messaging. £1 million is allocated to flu vaccination messaging.</p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/10/2015 14:39:51 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

420130

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what targets his Department has set for the uptake of seasonal influenza vaccination in each at-risk group for the winter of 2015-16.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	11109
answer	answer is ministerial correction date of answer 14/10/2015 answer text <p>A copy of the Annual Flu Plan and Annual Flu letter 2015/16 is attached, this provides guidance on the seasonal flu vaccination programme. In 2015-16, the seasonal flu vaccination will be offered to the following at risk-groups:</p><p>- people aged 65 years and over;</p><p>- people aged six months to under 65 with long-term conditions;</p><p>- pregnant women;</p><p>- people living in a residential or nursing home; and</p><p>- the main carer of an older or disabled person.</p><p>We also encourage all frontline health and social care workers to get the flu vaccination to help protect themselves, their families and the vulnerable patients they come into contact with.</p><p>This year we aim to reach a minimum 75% uptake for those aged 65 years and older, and frontline health and social care workers.</p><p><strong></strong></p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name Annual flu letter 2015-16.pdf title Annual flu letter 2015-16 2 file name Flu Plan 2015-16.pdf title Annual flu plan 2015-16 question first answered 14/10/2015 15:31:04 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

420131

registered interest
date	09/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the NHS spent on cancer services in each year since 2009-10; and what the year-on-year change in that amount was in real terms.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	11110
answer	answer is ministerial correction date of answer 14/10/2015 answer text <p>Due to the transition to new commissioning structures, it is not possible to create a time-series consistent with the years prior to 2012-13 because expenditure on some services covered by primary care trusts has transferred to local authorities and Public Health England.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/10/2015 15:05:35 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

417994

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether NHS England's high cost device steering group sought advice from clinicians and other healthcare professionals before recommending the removal of implantable cardiac defibrillators from the high cost device exclusion list.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9812
answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>Membership of the high cost devices steering group includes clinicians, commissioners and financial departments from trusts. NHS England also included discussion about the high cost devices being removed from tariff in the expert working group meeting on cardiology on the proposed price relativities. NHS England and Monitor are currently engaging on proposals in the national tariff and will consider feedback on proposals in the consultation on the 2016/17 National Tariff.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 17/09/2015 14:33:21 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

417995

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will ask NHS England to publish the minutes of meetings of the high cost device steering group at which the recommendation was made to remove subcutaneous implantable cardiac defibrillators from the high cost device exclusion list.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9813
answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>There is no plan to publish the minutes. It is important to note that the discussions about removing implantable cardiac defibrillators (ICD) devices from the high cost list related to all ICDs not just the subcutaneous ICDs.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 17/09/2015 14:46:39 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

417996

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with NHS England and Monitor about the proposal to remove subcutaneous implantable cardiac defibrillators from the high cost device exclusion list as part of the 2016-17 national tariff proposals.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9804
answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>The Health and Social Care Act 2012 gives responsibility for National Tariff to Monitor and NHS England. As such, Monitor and NHS England have worked with the relevant experts to propose changes to the high cost list, including removing implantable cardiac defibrillators from the high cost list. We are currently engaging on these proposals and will respond to this feedback in the proposals set out in the Consultation on the 2016/17 National Tariff.</p><p> </p><p> </p><p> </p><p>The Office for Life Science and the Department are conducting the Innovative Medicines and Medical Technology Review, which will be led by Sir Hugh Taylor. The review will make recommendations to Government on reform to accelerate access for NHS patients to innovative medicines and medical technologies (including devices and diagnostics).</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 17/09/2015 15:31:04 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

417997

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with NHS England about the criteria used to decide (a) when and (b) which high cost devices are removed from the high-cost drugs and devices list.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9695
answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>The Health and Social Care Act 2012 gives responsibility for the National Tariff to Monitor and NHS England. The criteria for listing a drug or device on the high cost list are set out on the NHS England website and are made clear as part of the engagement. When it is felt that there is sufficient evidence to remove a high cost device from the list, Monitor and NHS England propose this as part of a wider engagement and will gather wider views on the appropriateness of the change. All feedback will be reviewed to take a final view.</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 17/09/2015 15:28:08 answering member 3988 label Biography information for Ben Gummer
tabling member	1506 label Biography information for Andrew Gwynne

417998

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Heart Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that the NHS is an early adopter of innovation in regards to devices to prevent sudden cardiac death syndrome.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9711
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>Data on the number of implantations of subcutaneous implantable cardiac defibrillators and implantable cardiac defibrillators which took place in 2013-14, the last year for which data is available, are set out in the attached table.</p><p> </p><p> </p><p> </p><p>In 2013, the National Institute for Health and Care Excellence (NICE) produced Interventional Procedures Guidance on this technology for the prevention of sudden cardiac death, recommending that it should only be used with special arrangements for clinical governance, consent and audit or research.</p><p> </p><p> </p><p> </p><p>NICE’s interventional procedures guidance assesses the efficacy and safety of interventional procedures, with the aim of protecting patients and helping clinicians, healthcare organisations and the National Health Service to introduce procedures appropriately. This guidance is not subject to the same statutory funding direction as NICE’s technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>The Accelerated Access Review will make recommendations to the Government on reforms to accelerate access for NHS patients to innovative medicines and medical technologies (including devices, diagnostics and digital), making this country the best place in the world to design, develop and deploy these products. This includes looking at regulation, reimbursement, assessment and uptake.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9710 9712 question first answered 16/09/2015 15:43:11 answering member 3918 label Biography information for Jane Ellison attachment 1 file name FCEs implantable cardiac defibrillators (including subcutaneous) 2013-14.xlsx title Implantations of cardiac defibrillators 2013-14
tabling member	1506 label Biography information for Andrew Gwynne

417999

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many implantations of (a) subcutaneous implantable cardiac defibrillators and (b) implantable cardiac defibrillators took place within the NHS in the last year for which data is available.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9710
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>Data on the number of implantations of subcutaneous implantable cardiac defibrillators and implantable cardiac defibrillators which took place in 2013-14, the last year for which data is available, are set out in the attached table.</p><p> </p><p> </p><p> </p><p>In 2013, the National Institute for Health and Care Excellence (NICE) produced Interventional Procedures Guidance on this technology for the prevention of sudden cardiac death, recommending that it should only be used with special arrangements for clinical governance, consent and audit or research.</p><p> </p><p> </p><p> </p><p>NICE’s interventional procedures guidance assesses the efficacy and safety of interventional procedures, with the aim of protecting patients and helping clinicians, healthcare organisations and the National Health Service to introduce procedures appropriately. This guidance is not subject to the same statutory funding direction as NICE’s technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>The Accelerated Access Review will make recommendations to the Government on reforms to accelerate access for NHS patients to innovative medicines and medical technologies (including devices, diagnostics and digital), making this country the best place in the world to design, develop and deploy these products. This includes looking at regulation, reimbursement, assessment and uptake.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9711 9712 question first answered 16/09/2015 15:43:11 answering member 3918 label Biography information for Jane Ellison attachment 1 file name FCEs implantable cardiac defibrillators (including subcutaneous) 2013-14.xlsx title Implantations of cardiac defibrillators 2013-14
tabling member	1506 label Biography information for Andrew Gwynne

418000

registered interest
date	09/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Defibrillators
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure access for NHS patients to subcutaneous implantable cardiac defibrillators.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	9712
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>Data on the number of implantations of subcutaneous implantable cardiac defibrillators and implantable cardiac defibrillators which took place in 2013-14, the last year for which data is available, are set out in the attached table.</p><p> </p><p> </p><p> </p><p>In 2013, the National Institute for Health and Care Excellence (NICE) produced Interventional Procedures Guidance on this technology for the prevention of sudden cardiac death, recommending that it should only be used with special arrangements for clinical governance, consent and audit or research.</p><p> </p><p> </p><p> </p><p>NICE’s interventional procedures guidance assesses the efficacy and safety of interventional procedures, with the aim of protecting patients and helping clinicians, healthcare organisations and the National Health Service to introduce procedures appropriately. This guidance is not subject to the same statutory funding direction as NICE’s technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>The Accelerated Access Review will make recommendations to the Government on reforms to accelerate access for NHS patients to innovative medicines and medical technologies (including devices, diagnostics and digital), making this country the best place in the world to design, develop and deploy these products. This includes looking at regulation, reimbursement, assessment and uptake.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9710 9711 question first answered 16/09/2015 15:43:11 answering member 3918 label Biography information for Jane Ellison attachment 1 file name FCEs implantable cardiac defibrillators (including subcutaneous) 2013-14.xlsx title Implantations of cardiac defibrillators 2013-14
tabling member	1506 label Biography information for Andrew Gwynne